Literature DB >> 1374431

Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.

R Torenbeek1, C E Blomjous, J J Quak, S Ybema, C J Meijer.   

Abstract

AIMS: To investigate the localisation of the E48 epitope and to determine the use of monoclonal antibody E48 for the identification of transitional cell carcinomas (TCC); and to determine if antigenic expression was affected by different standard fixation methods.
METHODS: Biopsy specimens were labelled with E48 for immunoelectron microscopy. One hundred and nineteen tissue samples from 47 bladder carcinomas were tested for reactivity with E48, using fresh frozen, sublimate formalin, and formalin fixed tissue. Thirteen undifferentiated bladder tumours and 10 undifferentiated prostatic carcinomas were incubated with E48 and prostate specific antigen.
RESULTS: Reactivity to E48 was found in all grade 1 and 2 carcinomas and most (83%) grade 3 tumours. At the ultrastructural level, expression was mainly associated with desmosomes and the cytoplasmic membrane. The reactivity of E48 was generally strong in fresh frozen tissue samples and remained preserved in fixed tissue samples. Ten of the 13 bladder carcinomas expressed E48; all prostatic tumours were totally negative.
CONCLUSIONS: E48 is a sensitive marker for transitional cell carcinoma and suitable for differentiation between urothelial and prostatic undifferentiated carcinoma. It can be used in routinely processed, formalin fixed, biopsy specimens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374431      PMCID: PMC495269          DOI: 10.1136/jcp.45.4.303

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Cytokeratin expression during neoplastic progression of human transitional cell carcinomas as detected by a monoclonal and a polyclonal antibody.

Authors:  F Ramaekers; A Huysmans; O Moesker; G Schaart; C Herman; P Vooijs
Journal:  Lab Invest       Date:  1985-01       Impact factor: 5.662

2.  Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.

Authors:  J I Epstein; F P Kuhajda; P H Lieberman
Journal:  Hum Pathol       Date:  1986-09       Impact factor: 3.466

3.  Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.

Authors:  R Moll; T Achtstätter; E Becht; J Balcarova-Ständer; M Ittensohn; W W Franke
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

4.  Immunohistochemical expression of keratin proteins in urinary bladder carcinoma.

Authors:  M Asamoto; S Fukushima; Y Tatemoto; K Yamada; S Fukui; M Mori
Journal:  Pathol Res Pract       Date:  1989-02       Impact factor: 3.250

5.  Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases.

Authors:  K Sheibani; H Battifora; J S Burke; H Rappaport
Journal:  Am J Surg Pathol       Date:  1986-04       Impact factor: 6.394

Review 6.  Philip Levine award lecture. Blood group antigens as markers for normal differentiation and malignant change in human tissues.

Authors:  K O Lloyd
Journal:  Am J Clin Pathol       Date:  1987-01       Impact factor: 2.493

7.  Precursors of the blood group MN antigens as human carcinoma-associated antigens.

Authors:  G F Springer; P R Desai; M S Murthy; H J Yang; E F Scanlon
Journal:  Transfusion       Date:  1979 May-Jun       Impact factor: 3.157

8.  Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing.

Authors:  D K Chopin; J B deKernion; D L Rosenthal; J L Fahey
Journal:  J Urol       Date:  1985-08       Impact factor: 7.450

9.  Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude mice.

Authors:  J J Quak; A J Balm; J G Brakkee; R J Scheper; H J Haisma; B J Braakhuis; C J Meijer; G B Snow
Journal:  Int J Cancer       Date:  1989-09-15       Impact factor: 7.396

10.  A monoclonal antibody to human transitional cell carcinoma of the bladder: production and characterization.

Authors:  N Takahashi; S Takahashi; K Takahashi; T Suzuki; T Funyu
Journal:  J Urol       Date:  1987-07       Impact factor: 7.450

View more
  3 in total

1.  FOSL2 deficiency delays nonalcoholic steatohepatitis progression by regulating LY6D-mediated NLRP3 activation.

Authors:  Pei-Xin Hu; Mei-Yan Sheng; Yan-Ping Liu; Chun-Qing Zhang
Journal:  Hum Cell       Date:  2022-08-05       Impact factor: 4.374

2.  Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer.

Authors:  Nina Andersson; Johan Ohlsson; Sara Wahlin; Björn Nodin; Karolina Boman; Sebastian Lundgren; Karin Jirström
Journal:  Biomark Res       Date:  2020-10-07

3.  Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas.

Authors:  R Moll; X R Wu; J H Lin; T T Sun
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.